Unmasking viral invaders: Device used in physics reveals dynamics of pervasive pathogen

June 5, 2014

If you have it, you probably don't know it. Cytomegalovirus, or CMV, is perhaps one of the biggest pathogens you've never heard of—big, both proportionately and epidemiologically. It contains approximately 200 genes, compared to HIV's paltry 18, and it's everywhere. You can catch it as a preschooler salivating over blocks, or as a teenager experiencing your first kiss. Once you have it, you have it for life.

Good news: If you're healthy, it's harmless. Your T cells keep it in check, and you'll be none the wiser.

Bad news: If you have any medical condition that dampens your , such as HIV infection or a recent organ transplant, the virus can assert itself with a vengeance. The results, sometimes, are life-threatening.

Researchers in the lab of Steven Gygi, professor of cell biology at Harvard Medical School, report that they have discovered a menu of tactical secrets CMV employs. Using a technological platform commonly used in physics and chemistry called mass spectrometry, the researchers were able to describe the dynamics of a CMV infection in a fibroblast, or connective tissue cell, over a three-day course of infection. As a result the researchers discovered ways CMV evades the immune system, and also showed how certain target and destroy human proteins that defend against infection.

"This is an entirely new way of studying the behavior and tactics of viruses," said Gygi.

These results are published June 5 in Cell.

Mass spectrometry has existed for more than a century, used primarily by physicists and chemists to describe and measure small molecules. Inside the mass spectrometer, or mass spec tool, molecules are shattered by an electric charge and then brought through a magnetic field where they are characterized one by one.

Traditionally, this approach has not been relevant for the life sciences since biomolecules such as proteins are too large for this process. But over the last 15 years, Gygi has been innovating ways to incorporate mass spec into biology. In one approach, "electrospray," subunits of proteins called peptides are vaporized and then sprayed into a chamber where they are broken apart by helium. The mass spec then sequences the amino acids of each peptide. The molecules are "reassembled" through an algorithm that matches them to a database.

Michael Weekes, a postdoctoral researcher in the Gygi lab and an expert in infectious disease, decided to use mass spec for virology. He chose CMV because, for a virus that is so widespread, we actually know very little about it. "Many scientists are interested in CMV, but few if any have tried to tackle it in a comprehensive way before," he said.

Weekes took a sample of fibroblasts newly infected with CMV, harvested the proteins from both the virus and the cell, and sprayed them into the mass spec at different times over three days in order to construct a thorough trajectory of infection. The first three days of infection are particularly important since they mark a covert stage in which the virus hijacks, but hasn't yet destroyed, the cell.

The researchers were able to study approximately 8,000 total proteins, identifying not only ways that CMV evades the immune system, but also discovering a number of new therapeutic targets. Most notably, they were able to look closely at proteins that live on the . This is especially crucial since most drugs target , yet these proteins are harder to study than proteins inside the cell due to their low numbers.

Weekes and his colleagues found 29 viral proteins living on the cell surface, 23 of which had not previously been discovered. Many of these CMV surface proteins deter immune cells. Others block cellular proteins that activate immunity. In other words, CMV wards off rescuers while disabling a cell's ability to defend itself.

"So much of this viral genome is dedicated to simply evading the immune system," said Weekes.

The next step, according to the researchers, would be to identify antibodies against many of these viral proteins, ideally destroying infected cells before they replicate and spread the pathogen.

"This would be an entirely new way to combat CMV," said Weekes.

Explore further: People with leukaemia are more prone to infection – but not from one particular herpes virus

More information: "Quantitative Temporal Viromics: An Approach to Investigate Host-Pathogen Interaction." Michael P. Weekes, Peter Tomasec, Edward L. Huttlin, Ceri A. Fielding, David Nusinow, Richard J. Stanton, Eddie C.Y. Wang, Rebecca Aicheler, Isa Murrell, Gavin W.G. Wilkinson, Paul J. Lehner, Steven P. Gygi. Cell April 3, 2014.
dx.doi.org/10.1016/j.cell.2014.04.028

Related Stories

People with leukaemia are more prone to infection – but not from one particular herpes virus

March 19, 2014
People with chronic lymphocytic leukaemia (CLL) are essentially more prone to infections such as varicella, influenza or pneumococci due to the reduction in the number of antibodies that their condition causes. Researchers ...

New vaccine hope for leading viral cause of birth defects

April 10, 2014
(Medical Xpress)—Experts in infection and immunity have made a path-finding discovery that could lead to the development of a vaccine for a health-ravaging virus that affects around 50% of adults in the UK.

Common virus may cause anemia in patients with kidney disease

April 10, 2014
A virus that is present in most people in a latent state may induce or exacerbate anemia in patients with kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology ...

Novel vaccine approach to human cytomegalovirus found effective

September 18, 2013
An experimental vaccine against human cytomegalovirus (CMV) infection, which endangers the developing fetus, organ transplant recipients, patients with HIV and others who have a weakened immune system, proved safe and more ...

Researchers identify protein that helps control common viral infection

March 26, 2014
Infectious disease specialists at the Johns Hopkins Children's Center have identified a protein that regulates the body's immune response to cytomegalovirus (CMV), a common pathogen that causes lifelong infections and can ...

Test approved to help treat common infection in transplant patients

July 5, 2012
(HealthDay) -- The first DNA test to help doctors treat a common viral infection in people who have had a solid organ transplant has been approved by the U.S. Food and Drug Administration.

Recommended for you

A sodium surprise: Engineers find unexpected result during cardiac research

July 20, 2017
Irregular heartbeat—or arrhythmia—can have sudden and often fatal consequences. A biomedical engineering team at Washington University in St. Louis examining molecular behavior in cardiac tissue recently made a surprising ...

Want to win at sports? Take a cue from these mighty mice

July 20, 2017
As student athletes hit training fields this summer to gain the competitive edge, a new study shows how the experiences of a tiny mouse can put them on the path to winning.

Engineered liver tissue expands after transplant

July 19, 2017
Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available.

Lunatic Fringe gene plays key role in the renewable brain

July 19, 2017
The discovery that the brain can generate new cells - about 700 new neurons each day - has triggered investigations to uncover how this process is regulated. Researchers at Baylor College of Medicine and Jan and Dan Duncan ...

'Smart' robot technology could give stroke rehab a boost

July 19, 2017
Scientists say they have developed a "smart" robotic harness that might make it easier for people to learn to walk again after a stroke or spinal cord injury.

New animal models for hepatitis C could pave the way for a vaccine

July 19, 2017
They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.